Co-Authors
This is a "connection" page, showing publications co-authored by Ming-Hua Zheng and Kenneth Zheng.
Connection Strength
7.352
-
COVID-19 Cross-Infection and Pressured Ulceration Among Healthcare Workers: Are We Really Protected by Respirators? Front Med (Lausanne). 2020; 7:571493.
Score: 0.902
-
Extrapulmonary complications of COVID-19: A multisystem disease? J Med Virol. 2021 01; 93(1):323-335.
Score: 0.894
-
A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients. J Gen Intern Med. 2020 07; 35(7):2205-2206.
Score: 0.890
-
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism. 2020 07; 108:154244.
Score: 0.878
-
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front Endocrinol (Lausanne). 2021; 12:604100.
Score: 0.233
-
Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic. J Clin Transl Hepatol. 2021 02 28; 9(1):1-2.
Score: 0.232
-
Data sharing during COVID-19 pandemic: what to take away. Expert Rev Gastroenterol Hepatol. 2020 Dec; 14(12):1125-1130.
Score: 0.225
-
Abnormal liver enzymes in children and infants with COVID-19: A narrative review of case-series studies. Pediatr Obes. 2020 12; 15(12):e12723.
Score: 0.225
-
ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis. Am J Gastroenterol. 2020 09; 115(9):1544.
Score: 0.225
-
Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia. MedComm (2020). 2020 Aug 13.
Score: 0.224
-
Metabolic-associated fatty liver disease is associated with severity of COVID-19. Liver Int. 2020 09; 40(9):2160-2163.
Score: 0.223
-
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients. J Gastroenterol Hepatol. 2021 Jan; 36(1):204-207.
Score: 0.221
-
COVID-19 and liver transplantation: Lessons learned from three reported cases. Transpl Infect Dis. 2020 08; 22(4):e13335.
Score: 0.221
-
Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study. Nephron. 2020; 144(7):347-350.
Score: 0.221
-
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut. 2020 08; 69(8):1545-1547.
Score: 0.221
-
Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020 Jul; 43(7):e72-e74.
Score: 0.220
-
Fatal outcome in a liver transplant recipient with COVID-19. Am J Transplant. 2020 07; 20(7):1907-1910.
Score: 0.220
-
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis. J Hepatol. 2020 09; 73(3):719-721.
Score: 0.220
-
Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19. Metabolism. 2020 07; 108:154249.
Score: 0.220
-
COVID-19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020 04; 7(4):e351-e352.
Score: 0.219
-
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol. 2020 Mar 28; 8(1):18-24.
Score: 0.219